retatrutide trial phase Research Concentration Overview Retatrutide: Phase 3 Results (Up

But for millions of people already weighing whether to start a GLP-1 drug for diabetes, obesity, or another approved indication, it is one more factor worth considering

The New England Journal of Medicine , 389(24), 2221-2232

Poco frecuentes (1 de cada 100 usuarios) como aumento del pulso, alteracin del sentido del gusto, reacciones en el lugar de la inyeccin, pancreatitis y retraso en el vaciado gstrico Adems, algunos usuarios han reportado lo que se conoce coloquialmente como cara de Ozempic que describe cambios en el rostro como mejillas ms hundidas y piel ms flcida

Zepbound (tirzepatide) is a prescription medication that has been FDA-approved for adults with obesity or those who are overweight with at least one weight-related health condition

Its dual role in managing blood sugar and supporting weight loss makes it a valuable option for individuals struggling with both conditions

Never discontinue prescribed medication without consulting your healthcare provider, as abrupt cessation may lead to rapid weight regain and loss of metabolic benefits achieved during treatment